Press Articles
![]() |
3-D Endocavity probe knocks for targeted prostate procedures
March 2016 The prostate remains the only organ where random biopsies are performed to find cancer, notes Jean-Michel Correas MD PhD, from the Necker University Hospital in Paris. If we proposed this approach to a woman to search for breast cancer, it would be outrageous, he said. ... « With 3-D ShearWave Elastography, for the first time, we can clearly identify and target suspicious regions of the prostate with an ultrasound based technique and perform targeted and systematic biopsies with the same imaging modality and probe,’ Correas said. » |
![]() |
Ultrasound Technology: Q&A with Dr. James Trotter
November 09, 2015
HealthCare Business News spoke with Dr. James Trotter about advances in ultrasound technology for evaluating the liver. |
![]() |
New breast cancer screening device saves Knoxville woman’s life
By Lori Tucker Published: October 26, 2015
KNOXVILLE (WATE) – A breakthrough tool in breast cancer screening can tell you immediately if you have the disease. It saved the life of a Knoxville woman whose mammogram didn’t pick up the tiny lump in her breast.Chris Parker, 44, is one of many women this new diagnostic device can help. Parker, a wife and mother of two, moved to Knoxville with her family from Colorado three years ago to care for her mother-in-law, who ultimately died of ovarian cancer. It’s called the Aixplorer(...) |
![]() |
Ultrasounds Lead To 50% Reduction In Breast Biopsies
October 2015
When coming in for your annual mammogram, if there is something unusual detected, most radiologist's next step is to perform a biopsy to investigate further. These are usually scheduled a few days later. The time between the biopsies, let alone waiting for results, can be incredibly stressful. |
![]() |
New Pain-Free Alternative to Biopsy: evaluation, treatment and follow-up options for Hepatitis C patients
October 2, 2015. By James Trotter M.D.
Assessing liver fibrosis in Hepatitis C patients used to lead to a “least worst” decision: would it be better to treat the patient with early generation antiviral therapies, exposing him or her to damaging side effects for a 50/50 shot at a cure, or should the patient be monitored, via regular liver biopsies, as the untreated disease progresses? |